Can B Corp. (CANB) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Can B Corp. (CANB) trades at $0.01917 with AI Score 38/100 (Grade D). Can B Corp. specializes in the development and sale of cannabidiol (CBD) products, focusing on health and wellness. Market cap: $1.49M, Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for CANB: CANB does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CANB against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CANB: 3/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Can B Corp. (CANB) Healthcare & Pipeline Overview
Can B Corp. is a U.S.-based company focused on the development and manufacturing of a diverse range of CBD products, including oils, topical creams, and lifestyle items, capitalizing on the growing health and wellness market.
What Is the Investment Thesis for CANB?
Can B Corp. is positioned to capitalize on the expanding CBD market, which is projected to grow significantly as consumer awareness and acceptance of CBD products increase. The company’s diverse product lineup, which includes oils, creams, and lifestyle items, allows it to target various consumer segments seeking health and wellness solutions. Key value drivers include its established brand presence and distribution channels, which enhance market penetration. However, the company faces risks associated with operating in the OTC market, including liquidity challenges and regulatory scrutiny. Investors should monitor Can B Corp.'s ability to scale operations and achieve profitability in a competitive landscape, particularly as consumer demand for CBD products continues to rise.
Based on FMP financials and quantitative analysis
CANB Key Highlights
- Market Cap: $0.00B, indicating a very small company size and potential volatility.
- Beta: 0.85, suggesting lower volatility compared to the broader market.
- No dividend yield, reflecting a focus on reinvestment rather than shareholder returns.
- Employee count of 12, highlighting the company's small operational scale.
- Diverse product offerings including oils, topical creams, and lifestyle products, positioning the company well within the health and wellness sector.
Who Are CANB's Competitors?
CANB is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CURLF Curaleaf Holdings, Inc. | $9.13 | -2.56% | $2.41B | 53 |
| APHA APHA | $15.27 | -1.04% | 56 | |
| TLRY Tilray Brands, Inc. | $3.99 | -4.09% | $479M | 47 |
| HEXO HEXO Corp. | $0.71 | +2.45% | $31.2M | 50 |
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.13 | -16.67% | $36.0M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CANB's Key Strengths?
- Diverse product offerings catering to various consumer segments.
- Established brand names that enhance market recognition.
- Strong focus on health and wellness trends driving consumer interest.
- Ability to adapt to regulatory changes in the CBD market.
What Are CANB's Weaknesses?
- Small employee base leading to limited operational capacity.
- Trading on the OTC market may limit visibility and investor confidence.
- Lack of dividend payments may deter income-focused investors.
- Potential challenges in scaling operations to meet growing demand.
What Could Drive CANB Stock Higher?
- Potential expansion of product lines targeting new consumer segments.
- Continued growth in consumer interest in CBD products driving sales.
- Strategic partnerships with medical professionals enhancing distribution.
- Exploration of international markets for product distribution.
- Adaptation to regulatory changes in the CBD industry.
What Are the Key Risks for CANB?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Regulatory uncertainties that could impact product availability.
- Intense competition from both established and emerging CBD companies.
- Market volatility associated with trading on the OTC market.
- Changing consumer preferences that may affect product demand.
What Are the Growth Opportunities for CANB?
- Expansion of Product Lines: Can B Corp. has the opportunity to expand its product offerings within the CBD sector, targeting niche markets such as pet care and beauty products. The global CBD skincare market is projected to reach $1.7 billion by 2025, presenting a significant growth avenue for the company as it develops new formulations and leverages its existing brand presence.
- Increased Online Sales: With the rise of e-commerce, Can B Corp. can enhance its online sales strategy to reach a broader audience. The online health and wellness market is expected to grow significantly, driven by consumer preferences for convenience and accessibility. By optimizing its digital marketing efforts and expanding its online presence, Can B Corp. could capture a larger share of this growing market.
- Strategic Partnerships: Forming partnerships with healthcare professionals and wellness influencers can enhance Can B Corp.'s credibility and market reach. Collaborating with professionals in the health sector can facilitate product endorsements and increase consumer trust, potentially leading to higher sales and brand loyalty.
- Geographic Expansion: Can B Corp. can explore opportunities to expand its distribution network beyond the U.S. market. International markets, particularly in Europe and Asia, are increasingly receptive to CBD products, and establishing a presence in these regions could significantly boost the company's revenue potential.
- Regulatory Advancements: As regulations surrounding CBD products continue to evolve, Can B Corp. could benefit from favorable legislative changes that promote the use of CBD in various applications. Keeping abreast of regulatory developments and adapting its product offerings accordingly can position the company to capitalize on new market opportunities.
What Opportunities Does CANB Have?
- Expansion into international markets as global demand for CBD rises.
- Increased online sales potential due to e-commerce growth.
- Strategic partnerships with health professionals to enhance credibility.
- Development of new product lines targeting niche markets.
What Threats Does CANB Face?
- Intense competition from both established and emerging CBD companies.
- Regulatory uncertainties that could impact product availability.
- Market volatility associated with trading on the OTC market.
- Changing consumer preferences that may affect product demand.
What Are CANB's Competitive Advantages?
- Established brand presence with multiple product lines catering to diverse consumer needs.
- Strong relationships with healthcare professionals enhancing credibility.
- Diverse distribution channels, including e-commerce and vending machines, increasing accessibility.
- Focus on product quality and compliance with evolving regulations.
- Ability to adapt quickly to market trends and consumer preferences.
What Does CANB Do?
Founded in 2005, Can B Corp. has established itself as a key player in the cannabidiol (CBD) market, specializing in the development, manufacturing, and sale of CBD-derived products. Originally named Canbiola Inc., the company rebranded to Can B Corp. in February 2020 to better reflect its broad range of offerings and commitment to health and wellness. Headquartered in Hicksville, New York, Can B Corp. operates primarily within the United States, providing an extensive selection of hemp-based CBD products that includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, and concentrates. The company markets its products under several brand names, including Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil, catering to a diverse customer base. Can B Corp. sells its products through multiple channels, including its official website, automated vending machines, and partnerships with medical professionals, enhancing its market reach. With a relatively small workforce of 12 employees, Can B Corp. continues to navigate the competitive landscape of the CBD industry, which is characterized by increasing consumer interest in health and wellness products. As the market evolves, Can B Corp. aims to leverage its brand portfolio and product diversity to capture a larger share of the growing CBD market.
What Products and Services Does CANB Offer?
- Develop and manufacture a wide range of CBD products.
- Offer oils, topical creams, moisturizers, isolates, and gel capsules.
- Market products under various brand names including Canbiola and Nu Wellness.
- Sell products through an official website and automated vending machines.
- Collaborate with medical professionals for product distribution.
- Focus on health and wellness market trends to inform product development.
How Does CANB Make Money?
- Generate revenue through the sale of CBD products directly to consumers.
- Utilize multiple sales channels, including e-commerce and physical vending machines.
- Leverage partnerships with healthcare professionals to enhance product distribution.
- Focus on brand differentiation to capture diverse consumer segments.
- Adapt product offerings based on market demand and regulatory changes.
What Industry Does CANB Operate In?
The CBD market is experiencing rapid growth, driven by increasing consumer interest in health and wellness products. The global CBD market size was valued at approximately $2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of around 21% from 2021 to 2028. Can B Corp. operates in a competitive landscape that includes both established pharmaceutical companies and emerging startups focused on CBD products. As regulations evolve, companies like Can B Corp. must adapt to maintain compliance while capitalizing on market opportunities.
Who Are CANB's Key Customers?
- Health-conscious consumers seeking natural wellness solutions.
- Individuals interested in alternative therapies and supplements.
- Medical professionals looking to provide CBD products to patients.
- Retail partners interested in stocking CBD products.
- Consumers purchasing lifestyle products that incorporate CBD.
How Can B Corp. Is Valued
Can B Corp. carries a market capitalization of $1.49M, placing it in the micro-cap category. Relative to its peer group, CANB's quantitative score of 38/100 is below the peer average of 53/100.
ROE 38%Key Financial Metrics
Return on equity for Can B Corp. stands at 37.6%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -28.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 2/9Financial Health
Can B Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
CANB Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Diverse product offerings catering to various consumer segments.
- Established brand names that enhance market recognition.
- Strong focus on health and wellness trends driving consumer interest.
- Ability to adapt to regulatory changes in the CBD market.
Bear Case
- Small employee base leading to limited operational capacity.
- Trading on the OTC market may limit visibility and investor confidence.
- Lack of dividend payments may deter income-focused investors.
- Potential challenges in scaling operations to meet growing demand.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CANB Latest News
No recent news available for CANB.
CANB Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CANB.
Price Targets
Wall Street price target analysis for CANB.
CANB MoonshotScore
What does this score mean?
The MoonshotScore rates CANB 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Marco Alfonsi
CEO
Marco Alfonsi has a robust background in the healthcare and consumer packaged goods sectors. He has held various leadership roles that emphasize operational efficiency and market expansion. His educational credentials and industry experience position him well to lead Can B Corp. through its growth phases in the competitive CBD market.
Track Record: Under Marco Alfonsi's leadership, Can B Corp. has successfully rebranded from Canbiola Inc. to Can B Corp., reflecting its broader product range. His strategic focus on health and wellness has guided the company in navigating market challenges and leveraging growth opportunities.
CANB OTC Market Information
The OTC Other tier includes companies that do not meet the financial or regulatory requirements for higher tiers like NYSE or NASDAQ. These companies may have lower trading volumes and higher volatility, which can impact investor liquidity and market perception.
- OTC Tier: OTC Other
- Limited financial disclosures compared to companies listed on major exchanges.
- Higher volatility and risk of price manipulation in the OTC market.
- Potential challenges in raising capital due to lower visibility.
- Regulatory scrutiny that may impact operations and product offerings.
- Review the company's financial statements and operational performance.
- Verify the legitimacy of the company's product claims and certifications.
- Assess the competitive landscape and market positioning.
- Monitor regulatory developments affecting the CBD industry.
- Evaluate the company's growth strategy and market expansion plans.
- Established brand names with a history of product offerings.
- Partnerships with healthcare professionals enhancing credibility.
- Transparency in product sourcing and manufacturing processes.
Common Questions About CANB (Healthcare)
What does the AI Score mean for CANB?
CANB holds an AI Score of 38/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. Can B Corp. specializes in the development and sale of cannabidiol (CBD) products, focusing on health and wellness. The company operates primarily in the U.S. market, leveraging its diverse product …
What does Can B Corp. do?
Can B Corp. specializes in the development and sale of a wide range of CBD products, including oils, topical creams, and lifestyle items. The company operates primarily in the U.S. market and markets its products under various brand names such as Canbiola and Nu Wellness. Their offerings cater to health-conscious consumers seeking natural wellness solutions.
What are the main risks for CANB?
Can B Corp. faces several risks, including regulatory uncertainties that could affect product availability, intense competition from both established and emerging companies in the CBD market, and market volatility associated with trading on the OTC market. Additionally, changing consumer preferences may impact demand for their products, necessitating continuous adaptation and innovation.
How does Can B Corp. navigate regulatory approval processes?
Can B Corp. must comply with various federal and state regulations governing the sale of CBD products. This involves ensuring that their products meet safety and labeling standards set by regulatory bodies. The company actively monitors changes in legislation and adapts its product offerings to remain compliant, which is crucial for maintaining market access and consumer trust.
What are the key factors to evaluate for CANB?
Can B Corp. (CANB) holds an AI score of 38/100 (low). Not financial advice.
How frequently does CANB data refresh on this page?
CANB's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CANB's recent stock price performance?
Can B Corp. (CANB) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product offerings catering to various consumer segments. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CANB overvalued or undervalued right now?
Can B Corp. (CANB) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research CANB before investing?
Before investing in Can B Corp. (CANB), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The company operates in a highly regulated industry, and its financial performance may be influenced by external market conditions.